SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-016146
Filing Date
2020-04-09
Accepted
2020-04-09 17:07:40
Documents
5
Effectiveness Date
2020-04-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A aimt-defa14a_20200527.htm DEFA14A 36609
2 GRAPHIC g3kn53hpdxzm000004.jpg GRAPHIC 13178
3 GRAPHIC g3kn53hpdxzm000002.jpg GRAPHIC 70213
4 GRAPHIC g3kn53hpdxzm000001.jpg GRAPHIC 48628
5 GRAPHIC g3kn53hpdxzm000003.jpg GRAPHIC 25852
  Complete submission text file 0001564590-20-016146.txt   255668
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37519 | Film No.: 20785227
SIC: 2834 Pharmaceutical Preparations